HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of leukocyte adherence and aggregation for treatment of severe cold injury in rabbits.

Abstract
We tested the hypothesis that blocking neutrophil adherence and/or aggregation reduces tissue injury that results when tissue is frozen and rewarmed. The left hindlimbs of three groups of New Zealand White rabbits were immersed in a -15 degrees C salt water bath for 30 min to freeze the foot. The foot was rewarmed in a 39 degrees C water bath. In two groups, adherence and aggregation were blocked with monoclonal antibody (MAb) 60.3, and the third group was treated with saline. Two of the groups were treated at the time of rewarming with either saline or MAb 60.3, and the third group received MAb 60.3 at the conclusion of rewarming. Tissue edema and tissue loss were significantly less in the two groups receiving MAb 60.3 than in the control group. Rabbits treated at the time of rewarming had less edema and tissue loss than those treated at the completion of rewarming. These studies indicate that a substantial component of severe cold injury is neutrophil mediated and occurs after rewarming.
AuthorsW J Mileski, J F Raymond, R K Winn, J M Harlan, C L Rice
JournalJournal of applied physiology (Bethesda, Md. : 1985) (J Appl Physiol (1985)) Vol. 74 Issue 3 Pg. 1432-6 (Mar 1993) ISSN: 8750-7587 [Print] United States
PMID8482687 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Animals
  • Antibodies, Monoclonal (therapeutic use)
  • Body Temperature (drug effects)
  • Cell Adhesion (drug effects)
  • Cell Aggregation (drug effects)
  • Edema (physiopathology)
  • Extremities (pathology)
  • Frostbite (drug therapy, pathology)
  • Leukocyte Count
  • Leukocytes (drug effects)
  • Necrosis (pathology)
  • Neutrophils (drug effects)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: